Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Clearside Biomedical, Inc. logo — Revolutionizing the delivery of therapies to the back of the...

Clearside Biomedical, Inc.

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®)

Founded 2012 39 employees Post-IPO Equity Total: $203.90M Biotechnology, Health Care +3

General Information

Company Name Clearside Biomedical, Inc.
Founded Year 2012
Founders / Decision Makers
Team member Team member
Employees 39
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Clearside Biomedical, Inc.. To contact Clearside Biomedical, Inc., visit clearsidebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Clearside Biomedical, Inc. compare?

A PDF of Clearside Biomedical, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Clearside Biomedical, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Clearside Biomedical, Inc.

Clearside Biomedical, Inc. is a biopharmaceutical company that is revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The company's proprietary SCS Microinjector® enables a non-surgical procedure for the targeted and compartmentalized delivery of therapies to the macula, retina, or choroid, potentially preserving and improving vision in patients with sight-threatening eye diseases. Clearside is also developing a pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. XIPERE™, Clearside's first product, was recently approved by the U.S. Food and Drug Administration in October 2021. Founded in 2011, the company operates in the biotechnology, health care, and pharmaceutical industries. Clearside secured a $15.00M Post-IPO Equity investment on 07 February 2024, signaling investor confidence in its innovative approach to ocular drug delivery. The absence of specific headquarters information or disclosed investors in the latest round leaves potential for further analysis of the company's financial and strategic outlook. With its groundbreaking approach and recent investment, Clearside Biomedical appears to be positioned for continued growth and impact in revolutionizing eye care treatments.

Business keywords: Ophthalmic company, Biopharmaceutical, Ocular microinjection platform, Retinal disease, Uveitis, Diabetic macular edema, Wet-AMD, Suprachoroidal space, Therapeutic products, Ophthalmology, Microinjector technology, Drug delivery, Non-surgical procedure, Atlanta, Georgia, CLS1001

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $15.00M -
07 Feb 2024
Post IPO Debt $65.00M 1
HealthCare Royalty Partners
HealthCare Royalty Partners
08 Aug 2022
Post IPO Equity $70.00M 1
RMI Partners
RMI Partners
07 Jun 2016
Series C $20.00M 4
Aju IB Investment Perceptive Advisors Rock Springs Capital
Aju IB Investment, Perceptive Advisors +2
03 Dec 2015
Series B $16.00M 5
Hatteras Venture Partners Georgia Research Alliance Venture Fund RMI Partners
Hatteras Venture Partners, Georgia Research Alliance Venture Fund +3
02 Sep 2014
Venture Round $6.00M -
12 May 2014
Series A $7.90M 3
Hatteras Venture Partners GRA Venture Fund
Hatteras Venture Partners, GRA Venture Fund +1
12 Feb 2013
Series A $4.00M 2
Hatteras Venture Partners GRA Venture Fund
Hatteras Venture Partners, GRA Venture Fund
05 Jan 2012

Clearside Biomedical, Inc. Alternatives & Competitors

View All Alternatives
Clearside Biomedical, Inc. vs
Oculis
Oculis Switzerland

Visionary Innovation

Post-IPO Equity
77 employees
Biotechnology, Health Care
Compare Clearside Biomedical, Inc. vs Oculis
Clearside Biomedical, Inc. vs
KriyaBio SA
KriyaBio SA Switzerland

Enabling topical ocular administration of biologics

Non Equity Assistance
2 employees
Biopharma, Biotechnology
Compare Clearside Biomedical, Inc. vs KriyaBio SA
Clearside Biomedical, Inc. vs
Replenish, Inc.
Replenish, Inc. United States

Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion...

Venture round
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Clearside Biomedical, Inc.

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®)
Clearside Biomedical, Inc. was founded in 2012.
Clearside Biomedical, Inc. operates in Biotechnology, Health Care, Health and Wellness, Medical Devices and Pharmaceutical. Its work centres on Ophthalmic company, Biopharmaceutical, Ocular microinjection platform and Retinal disease.
Clearside Biomedical, Inc. has approximately 39 employees.
Clearside Biomedical, Inc. has completed 8 funding rounds, raising a total of $203.90M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Clearside Biomedical, Inc. include Oculis, KriyaBio SA, Replenish, Inc., Vinci Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Clearside Biomedical, Inc. and Oculis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Clearside Biomedical, Inc., https://bouncewatch.com/company/clearside-biomedical-inc, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout